82
71
Growth Score 82 in past quarter
-7 pts
Heat Score 71 in past quarter
-20 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
663867
SeleXel is a biotechnology company whose mission is to develop efficient therapeutic solutions.
About the Company
SeleXel is a biotechnology company whose mission is to develop efficient therapeutic solutions in Oncology using a very innovative technology: RNA interference.
This natural biological mechanism allows to very specifically impair the synthesis of proteins required for the development of a cancer.
SeleXel concentrates its initial efforts on the
development of drugs treating prostate cancers that became resistant to conventional hormonal treatments.
The company develops a portfolio of siRNAs blocking cancer spreading (metastasis), and restoring the ability of the immune system to eliminate the tumor.